NCT06536283View on ClinicalTrials.gov

Opiophobia in Postsurgical Adults With Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Opiophobia
Interventions
OTHER

13-item Barriers Questionnaire (BQ-13)

Given by questionnaire

OTHER

Four-item Medication Adherence Questionnaire

Given by questionnaire

OTHER

14-item Hospital Anxiety and Depression Scale (HADS)

Given by questionnaire

Trial Locations (1)

77030

The Univerisity of Texas M. D. Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Sigma Theta Tau International

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT06536283 - Opiophobia in Postsurgical Adults With Cancer | Biotech Hunter | Biotech Hunter